The legacy of Viagra, and its developer copyright, presents a challenging case study for investors. Originally a blockbuster drug, producing billions in income, its exclusivity period created a deluge of generic competition , significantly impacting its market share . While specific firms may seek to capitalize on related treatments , the existing